Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POM121 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | PPP6R3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ENKD1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | CDK7 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | RP11-231C18.3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ARPC1B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | LIN7A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | MT-ND4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | STXBP2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZNF14 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |